255 related articles for article (PubMed ID: 24008687)
1. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice.
Xiong H; Zheng C; Wang J; Song J; Zhao G; Shen H; Deng Y
J Alzheimers Dis; 2013; 37(3):623-35. PubMed ID: 24008687
[TBL] [Abstract][Full Text] [Related]
2. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice.
Chen S; Sun J; Zhao G; Guo A; Chen Y; Fu R; Deng Y
Neurochem Res; 2017 Aug; 42(8):2326-2335. PubMed ID: 28382596
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.
Yang Y; Zhang J; Ma D; Zhang M; Hu S; Shao S; Gong CX
J Alzheimers Dis; 2013; 37(3):637-48. PubMed ID: 23948890
[TBL] [Abstract][Full Text] [Related]
5. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
Ma DL; Chen FQ; Xu WJ; Yue WZ; Yuan G; Yang Y
J Neurochem; 2015 Oct; 135(2):301-8. PubMed ID: 26183127
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
[TBL] [Abstract][Full Text] [Related]
7. (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.
Li L; Zhang ZF; Holscher C; Gao C; Jiang YH; Liu YZ
Eur J Pharmacol; 2012 Jan; 674(2-3):280-6. PubMed ID: 22115895
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
9. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and its metabolite N(1)-acetyl-N(1)-formyl-5-methoxykynuramine improve learning and memory impairment related to Alzheimer's disease in rats.
Rong K; Zheng H; Yang R; Liu X; Li L; Chen N; Zhao G; Gong C; Deng Y
J Biochem Mol Toxicol; 2020 Feb; 34(2):e22430. PubMed ID: 31833155
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
[TBL] [Abstract][Full Text] [Related]
12. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Liu P; Cui L; Liu B; Liu W; Hayashi T; Mizuno K; Hattori S; Ushiki-Kaku Y; Onodera S; Ikejima T
Physiol Behav; 2020 Jan; 213():112689. PubMed ID: 31669775
[TBL] [Abstract][Full Text] [Related]
13. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
Shu X; Zhang Y; Li M; Huang X; Yang Y; Zeng J; Zhao Y; Wang X; Zhang W; Ying Y
Neuropharmacology; 2019 Jul; 153():1-12. PubMed ID: 31015047
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting.
Zhang Y; Xie JZ; Xu XY; Hu J; Xu T; Jin S; Yang SJ; Wang JZ
Neurosci Bull; 2019 Aug; 35(4):724-734. PubMed ID: 30632006
[TBL] [Abstract][Full Text] [Related]
15. Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats.
Liu P; Zou L; Jiao Q; Chi T; Ji X; Qi Y; Xu Q; Wang L
Neurosci Lett; 2013 May; 543():115-20. PubMed ID: 23562514
[TBL] [Abstract][Full Text] [Related]
16. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice.
Cao Y; Liu B; Xu W; Wang L; Shi F; Li N; Lei Y; Wang J; Tian Q; Zhou X
Brain Res Bull; 2020 Sep; 162():166-179. PubMed ID: 32599128
[TBL] [Abstract][Full Text] [Related]
18. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.
Gao C; Liu Y; Jiang Y; Ding J; Li L
Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968
[TBL] [Abstract][Full Text] [Related]
19. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
